Department of Zoology, University of Rajasthan, Jaipur, Rajasthan, India
Received : 29th July, 2017; Revised : 30th August, 2017
Abstract : Cervical cancer (CC) is one of the most common types of gynecological malignancies worldwide that is particularly prevalent in the developing countries. Cervical cancer happens when cells change in women’s cervix, which connects their uterus with vagina. This cancer can affect the deeper tissues of their cervix and may spread to other parts of their body (metastasize), often the lungs, liver, bladder, vagina, and rectum. Prevention of cervical cancer very much relates to the prognostic and predictive biomarkers. To save many lives these markers are very important, as they help in taking clinical decisions at earliest. In this paper a comprehensive analysis of metabolite profiling technologies is performed.Metabolite profiling may allow us to extend diagnostic tests of cancer, and metabolite derivatives can be used for the molecular imaging of cancer.
Be First to Comment